Esophageal cancer is a disease difficult to treat. Divided into two main curative and palliative treatment schedule. Determining the treatment regimen, patient characteristics (age, KPS'u low, and cachectic patients with chronic disease morbidity and mortality is higher), cancer pathology (ADK SCC prognosis is better), stage (early diagnosis increases the chance of cure) and localization (1 / 3 chance of resection is limited localized in the upper region, 1 / 3 localized in the sub-region has a good chance of resection), and evaluated many factors including the patient, single-modality treatment, simultaneous treatment or palliative treatment is one of the options.
However, some patients can not tolerate treatment with multi-modal. In accordance with single-modality treatment in selected patients as either radiotherapy alone (RT) or surgery is preferred.
Treatment Options for Esophageal
Handbook of Evidence-based Radiation Oncology treatment option suggestions are as follows:
Stage I-II-III (resectable): Surgical (close or positive surgical margins + RT)
Neoadjuvant Chemoradiotherapy (KRT) + Surgical
(T2NOMO Perinodal cases of invasion (PNI) (+), lymphovascular invasion (LVI) (+)
or age <40 is, neoadjuvant CRT can be added.)
Definitive CRT (cervical esophageal cancer is preferred.)
Stage I-II-III (inoperable): a definitive CRT
Stage IV: The definitive CRT, only RT, chemotherapy (CT), applicable to any one of the best care options.